NZ768504A - Composition for improving skin conditions - Google Patents

Composition for improving skin conditions

Info

Publication number
NZ768504A
NZ768504A NZ768504A NZ76850419A NZ768504A NZ 768504 A NZ768504 A NZ 768504A NZ 768504 A NZ768504 A NZ 768504A NZ 76850419 A NZ76850419 A NZ 76850419A NZ 768504 A NZ768504 A NZ 768504A
Authority
NZ
New Zealand
Prior art keywords
skin conditions
composition
skin
improving
lactococcus
Prior art date
Application number
NZ768504A
Other languages
English (en)
Inventor
Ryohei Tsuji
Munekimi NANAO
Toshio Fujii
Takeshi Kokubo
Original Assignee
Kirin Holdings Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Holdings Kk filed Critical Kirin Holdings Kk
Publication of NZ768504A publication Critical patent/NZ768504A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ768504A 2018-03-15 2019-03-15 Composition for improving skin conditions NZ768504A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018048311A JP6846376B2 (ja) 2018-03-15 2018-03-15 皮膚状態改善用組成物
PCT/JP2019/010773 WO2019177139A1 (ja) 2018-03-15 2019-03-15 皮膚状態改善用組成物

Publications (1)

Publication Number Publication Date
NZ768504A true NZ768504A (en) 2025-08-29

Family

ID=67906705

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ768504A NZ768504A (en) 2018-03-15 2019-03-15 Composition for improving skin conditions

Country Status (8)

Country Link
US (1) US11497778B2 (enExample)
EP (1) EP3766363A4 (enExample)
JP (1) JP6846376B2 (enExample)
CN (1) CN111818812B (enExample)
AU (1) AU2019233471B2 (enExample)
NZ (1) NZ768504A (enExample)
SG (1) SG11202008959RA (enExample)
WO (1) WO2019177139A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3036937C (en) * 2016-09-15 2023-01-17 Kirin Company, Limited Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
KR102754494B1 (ko) * 2020-10-30 2025-01-14 중앙대학교 산학협력단 락토코커스 중앙젠시스를 포함하는 피부 손상 예방 또는 치료용 조성물
JP2022145446A (ja) * 2021-03-19 2022-10-04 キリンホールディングス株式会社 紙臭が抑制された容器詰茶飲料、及びその製造方法
JP7248250B2 (ja) * 2021-04-28 2023-03-29 キリンホールディングス株式会社 乳酸球菌の増殖促進剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3715640B1 (ja) 2004-09-01 2005-11-09 フジッコ株式会社 ストレス由来の皮膚血流低下改善用組成物、皮膚機能改善用組成物およびそれらを用いた飲食品
WO2009066537A1 (ja) * 2007-11-19 2009-05-28 Meiji Dairies Corporation 免疫調節性機能誘導剤及び食品組成物
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US9439933B2 (en) 2010-06-28 2016-09-13 Kabushiki Kaisha Yakult Honsha Skin properties improving agent for oral administration
BR112013016690A2 (pt) * 2010-12-28 2016-10-04 Kirin Holdings Kk agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante
JP2013233097A (ja) * 2012-05-07 2013-11-21 Koiwai Nyugyo Kk 風味良好なドリンクタイプヨーグルト
KR101693574B1 (ko) 2014-09-23 2017-01-06 한국 한의학 연구원 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물
JP6713751B2 (ja) * 2015-10-26 2020-06-24 キリンホールディングス株式会社 抗原に対する特異的な細胞傷害性ｔ細胞（ｃｔｌ）及び抗体産生を増強させる方法
CA3036937C (en) 2016-09-15 2023-01-17 Kirin Company, Limited Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin

Also Published As

Publication number Publication date
JP2019156793A (ja) 2019-09-19
EP3766363A4 (en) 2022-01-05
AU2019233471B2 (en) 2024-03-28
US11497778B2 (en) 2022-11-15
US20210008127A1 (en) 2021-01-14
EP3766363A1 (en) 2021-01-20
WO2019177139A1 (ja) 2019-09-19
CN111818812B (zh) 2023-09-26
JP6846376B2 (ja) 2021-03-24
CN111818812A (zh) 2020-10-23
AU2019233471A1 (en) 2020-10-22
SG11202008959RA (en) 2020-10-29

Similar Documents

Publication Publication Date Title
NZ768504A (en) Composition for improving skin conditions
MX2020008777A (es) Inmunoterapias relacionadas con el microbioma.
MX2021016034A (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella.
MX2021010868A (es) Bacteria de la familia christensenellaceaeas en la prevencion y/o tratamiento de enfermedades inflamatorias cronicas y/o enfermedades gastrointestinales inflamatorias y/o canceres.
SG11201807500RA (en) Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
NZ751231A (en) Silk-derived protein for treating inflammation
EP2578214A4 (en) PHARMACEUTICAL COMPOSITION WITH RAMALIN FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES
MX2020006191A (es) Bacteriocinas terapeuticas.
WO2018094023A3 (en) Cyclic dipeptides and wound healing
MX2017004662A (es) Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.
MX2018008903A (es) COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
PH12019501439B1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2018005352A (es) Metodos y composiciones para el tratamiento de amiloidosis.
MY162731A (en) Use of chelating agent and peptide antimicrobial compounds
MY194448A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
SG11201807616RA (en) Proliferative agent for faecalibacterium
WO2020016655A3 (en) Treatment of neuropathy with dna constructs expressing igf-1 isoforms
PH12021551703A1 (en) Composition comprising tolfenpyrad and pyraclostrobin
CA3084461C (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIBODY THAT BINDS SPECIFICALLY TO THE N-TERMINAL END OF LYSYL TRANSFER RIBONUCLE ACID (NTRNA) SYNTHETASE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF A DISEASE RELATED TO IMMUNE CELL MIGRATION
ZA202200273B (en) Animal food composition
EP4327815A3 (en) Probiotics for regulating blood glucose
WO2020139020A3 (ko) 헬리코박터 파일로리 연관 질환의 예방 또는 치료용 김치
MX2022004785A (es) Metodos y composiciones para el tratamiento del sindrome de rett.
WO2020025657A9 (en) Composition for use in the prevention and/or treatment of the genitourinary mucosa